Drug Markets/Erenumab-Aooe

Erenumab-Aooe

2 NDCs across 1 manufacturer|0 Generic,2 Brand

▸ More about this market

In 2024, Medicare Part D spent $306 million on Erenumab-Aooe across 338,000 claims for 56,000 beneficiaries.

Erenumab-Aooe is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $753.33 to $753.57 per ML — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

2

0G / 2B

Manufacturers

1

competing in market

Price Spread

$753.33 – $753.57

per ML

7d Activity

1↓0 flat

avg -0.0% WoW · of 2 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing ERENUMAB-AOOE

Drug Portfolio

2 NDCs total, 2 shown

Drug ↕Price 7d Change ↕
AIMOVIG 70 MG/ML AUTOINJECTOR
$753.5710
per ML
0.00%
AIMOVIG 140 MG/ML AUTOINJECTOR
$753.3259
per ML
-0.01%

Frequently Asked Questions

How much does Medicare spend on Erenumab-Aooe?

In 2024, Medicare Part D spent $306 million on Erenumab-Aooe across 338,000 claims for 56,000 beneficiaries.

How many Erenumab-Aooe products are on the market?

The Erenumab-Aooe drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.

What is the price range for Erenumab-Aooe?

NADAC reference prices for Erenumab-Aooe range from $753.3259 to $753.5710 per ML — a 0% difference between cheapest and most expensive.

Which manufacturers make Erenumab-Aooe?

1 manufacturer lists Erenumab-Aooe in NADAC. Ranked by number of NDCs, the largest are Amgen Inc. (2).

How has the price of Erenumab-Aooe changed recently?

Over the past 7 days, 0 Erenumab-Aooe NDCs rose and 1 fell, with a market-wide average change of -0.0%.